Butterfly network

VitalConnect Announces Addition of Heather Getz to Board of Directors

Retrieved on: 
화요일, 8월 9, 2022
Biotechnology, Managed Care, Health, Medical Devices, Data Management, Hospitals, Wearables, Mobile Technology, Technology, Biomedical engineering, Cardinal Health, Master of Business Administration, Chief administrative officer, CEO, NYSE, American Institute, Butterfly network, Northwell Health, Growth, Technology, American Institute of Certified Public Accountants, Board, Biotelemetry, Central Pennsylvania Institute of Science and Technology, Knowledge, Compliance, Founder, Patient, Villanova University, Executive, Strategic planning, Health, National Investor Relations Institute, CPA, CMS, Business administration, Board of directors, Healthy.io, Physician, MBA, CPAS, Certified Public Accountant, Management, Hospital, Brigham

VitalConnect , Inc. , a leader in remote and in-hospital wearable biosensor technology, today announced the addition of Heather C. Getz, CPA, MBA, to its Board of Directors.

Key Points: 
  • VitalConnect , Inc. , a leader in remote and in-hospital wearable biosensor technology, today announced the addition of Heather C. Getz, CPA, MBA, to its Board of Directors.
  • Getz brings more than 25 years of corporate experience creating long-term value through financial, general management, and healthcare leadership.
  • The addition of Heather Getz to our board brings us significant experience across a broad spectrum of successful companies in the healthcare space, said Dr. Nersi Nazari, Executive Chairman and Founder, VitalConnect.
  • Heathers experience and financial acumen brings a wealth of knowledge to our board at VitalConnect and were thrilled to have her, said Peter Van Haur, CEO of VitalConnect.

Butterfly Files Motion to Dismiss Claims in FUJIFILM Sonosite Legal Action

Retrieved on: 
월요일, 8월 8, 2022
Software, Radiology, Hardware, General Health, Health, Health Technology, Technology, Semiconductor, U.S. Securities and Exchange Commission, United Kingdom, Omicron, NYSE, Technology, Growth, Patent, Butterfly, Humanitarian use licenses, Annual report, Security (finance), New, Marketing, Patient, COVID-19, Company, Partnership, FUJIFILM, Network, Private Securities Litigation Reform Act, Butterfly network, Complaint, Medical imaging

Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today filed a motion to dismiss claims and specific patents from a complaint for patent infringement lawsuit filed on March 9, 2022, by FUJIFILM Sonosite Inc. Butterfly believes the lawsuit alleging infringement of U.S. Patent Nos.

Key Points: 
  • Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today filed a motion to dismiss claims and specific patents from a complaint for patent infringement lawsuit filed on March 9, 2022, by FUJIFILM Sonosite Inc. Butterfly believes the lawsuit alleging infringement of U.S. Patent Nos.
  • Butterfly will vigorously defend against FUJIFILM Sonosites accusations.
  • Butterflys Senior Vice President and Chief Legal Officer Larry Weiss said Were disappointed that FUJIFILM Sonosite chose this approach.
  • We believe this litigation is an attempt by FUJIFILM Sonosite Inc. to distract from its failure to innovate and keep pace with Butterflys next generation clinical assessment platform.

Butterfly Network, Inc. to Report Second Quarter 2022 Financial Results on August 3, 2022

Retrieved on: 
목요일, 7월 21, 2022
Technology, Health, Semiconductor, Medical Devices, United Kingdom, Butterfly network, Network, NYSE, Telephone, New, Webcast, Technology, Butterfly, Mobile phone, Medical imaging

Butterfly Network, Inc. (NYSE: BFLY) (Butterfly), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report second quarter 2022 financial results and provide a business update on August 3, 2022, before the market opens.

Key Points: 
  • Butterfly Network, Inc. (NYSE: BFLY) (Butterfly), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report second quarter 2022 financial results and provide a business update on August 3, 2022, before the market opens.
  • Dr. Todd Fruchterman, President and Chief Executive Officer, and Heather Getz, Chief Financial Officer, will host a conference call and webcast at 8:30 am ET on August 3, 2022, to discuss second quarter 2022 financial results and operational progress.
  • Through its proprietary Ultrasound-on-Chip technology, Butterfly is paving the way for earlier detection and remote management of health conditions around the world.
  • Butterfly iQ+ is a prescription device intended for qualified healthcare professionals only.

BFLY STOCK NEWS: Robbins LLP Investigates Butterfly Network, Inc. (BFLY) on Behalf of Shareholders

Retrieved on: 
수요일, 5월 18, 2022
Legal, Professional Services, Butterfly network, NYSE, Butterfly, Medical imaging

Shareholder rights law firm Robbins LLP announces that it is investigating Butterfly Network, Inc. (NYSE: BFLY) to determine whether certain Butterfly officers and directors breached fiduciary duties to shareholders.

Key Points: 
  • Shareholder rights law firm Robbins LLP announces that it is investigating Butterfly Network, Inc. (NYSE: BFLY) to determine whether certain Butterfly officers and directors breached fiduciary duties to shareholders.
  • Butterfly is a digital health company that develops and manufactures ultrasound imaging solutions.
  • Butterfly Network, Inc. (BFLY) shareholders have legal options.
  • If you own shares of Butterfly Network, Inc. contact us for more information about your rights.

Inogen Names Agnes Lee as Senior Vice President of Investor Relations and Strategic Planning

Retrieved on: 
수요일, 5월 18, 2022
Communications, Health, Medical Devices, Public Relations, Investor Relations, Senior, Regulation Fair Disclosure, Company, ResMed, Private Securities Litigation Reform Act, Strategic planning, Butterfly network, U.S. Securities and Exchange Commission, Applied Biosystems, Disclosure, Patient, Goal, International relations, NASDAQ, Investor relations, Fluidigm, Marketing, Indiana University Bloomington, Regulation, Research, Northwestern University, Forward-looking statement, Communication, Life Technologies, Thermo Fisher Scientific, Security (finance), Indiana University, Kellogg School, Annual report, Management, Risk management, Economics, Butterfly

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Agnes Lee to the position of Senior Vice President of Investor Relations and Strategic Planning, effective May 23, 2022.

Key Points: 
  • Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Agnes Lee to the position of Senior Vice President of Investor Relations and Strategic Planning, effective May 23, 2022.
  • Agnes joins Inogen from Butterfly Network, where she served as Vice President of Investor Relations.
  • Prior to Butterfly, she led proactive investor relations programs at Fluidigm and ResMed, Inc., playing pivotal roles in communicating changes in strategy, and global investor marketing.
  • She started her investor relations career at Life Technologies, which was acquired by Thermo Fisher Scientific in 2014.

Butterfly Network to Present at the UBS Global Healthcare Conference 2022

Retrieved on: 
금요일, 5월 13, 2022
Biotechnology, Radiology, Health, Medical Devices, Butterfly network, New, Event, Network, Butterfly, United Kingdom, Conference, Technology, CFO, NYSE, CEO, Medical imaging

Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a digital health company transforming care with handheld, whole-body ultrasound, today announced that it will participate in the UBS Global Healthcare Conference to be held in New York, NY, on May 23-25, 2022.

Key Points: 
  • Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a digital health company transforming care with handheld, whole-body ultrasound, today announced that it will participate in the UBS Global Healthcare Conference to be held in New York, NY, on May 23-25, 2022.
  • A live webcast of the fireside chat and an archived recording will be available in the Events & Presentations section of the Butterfly Network investor website.
  • Through its proprietary Ultrasound-on-Chip technology, Butterfly is paving the way for earlier detection and remote management of health conditions around the world.
  • Butterfly iQ+ is a prescription device intended for trained healthcare professionals only.

Butterfly Network Strengthens Executive Team with Two C-Suite Appointments

Retrieved on: 
목요일, 5월 12, 2022
Technology, Medical Devices, Semiconductor, Other Technology, Other Health, Hardware, Radiology, General Health, Health, Data Management, People, Senior, Company, Novartis Institute for Tropical Diseases, U.S. Securities and Exchange Commission, Butterfly network, Genzyme, Biomedical Research, Emulate, New, Patient, Therapy, Network, Butterfly, COVID-19, Marketing, United Kingdom, Culture, CPO, Industry, Inclusion, Partnership, Omicron, Humanitarian use licenses, Technology, General counsel, Corporation, Private Securities Litigation Reform Act, Security (finance), Human resources, Analog Devices, Growth, Medtronic, NYSE, Annual report, Management, Pharmaceutical industry, Medical imaging, Risk management, Akebia, Covidien

I look forward to working with and alongside Tamara and Larry in their new roles with Butterfly.

Key Points: 
  • I look forward to working with and alongside Tamara and Larry in their new roles with Butterfly.
  • Tamara joins Butterfly from Akebia Therapeutics where she served as Senior Vice President of Human Resources and Chief People Officer.
  • Im excited and proud to step into this role and be part of the Butterfly team.
  • Butterfly is pursuing a goal that is both important and transformative; I am honored to come aboard and be part of the talented Butterfly team.

Butterfly Network Recognized As "Best New Ultrasound Solution" in 2022 MedTech Breakthrough Awards Program

Retrieved on: 
월요일, 5월 9, 2022
EHR, New, Use, Butterfly network, Artificial intelligence, MHealth, Telehealth, Traction, CEO, Technology, Genomic and Medical Data, NYSE, Patient, Hospital, Medtech, Medical device, Head, Android, PACS, EMR, Research, General practice, Leadership, Acquisition, United Kingdom, Patient engagement in Canada, Global health, Fitness, Exercise, Diagnosis, Health, BMJ Open, IOS, Electronic health record, Medical imaging, Butterfly

LOS ANGELES, May 9, 2022 /PRNewswire-PRWeb/ -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced that Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, has been selected as the winner of the "Best New Ultrasound Solution" award in the sixth annual MedTech Breakthrough Awards program.

Key Points: 
  • Butterfly's groundbreaking ultrasound solution, Butterfly iQ+, is the world's only ultrasound transducer that can perform whole-body imaging in a single, handheld probe.
  • Fusing semiconductors, artificial intelligence, and cloud technology, Butterfly iQ+ is designed to enable the practical application of ultrasound information into the clinical workflow.
  • "We are honored to be recognized by MedTech Breakthrough for our Butterfly iQ+ innovation," said Dr. Todd Fruchterman, President and CEO of Butterfly Network.
  • Additionally, Butterfly Blueprint is Butterfly Network's system-wide platform designed to support the scaled deployment of ultrasound across hospitals and health systems.

Butterfly Network Reports First Quarter 2022 Financial Results

Retrieved on: 
목요일, 5월 5, 2022
Radiology, General Health, Health, Medical Devices, Technology, Semiconductor, Other Technology, Other Health, GAAP, New, Adjacent, Petco, Access code, Annual report, NEJM, Butterfly network, Humanitarian use licenses, Midwife toad, Technology, AI, Net, Investor, Mission statement, Bill & Melinda Gates Foundation, Company, NYSE, Patient, Network, Partnership, Forecasting, Cyprus Securities and Exchange Commission, Interest, Fowler & Wells Company, EBITDA, Omicron, UNC, Security (finance), International, Private Securities Litigation Reform Act, Growth, United Kingdom, COVID-19, Health, Economic system, Review, Marketing, Bill, Video game, Medical imaging, Bookkeeping, Bank, Risk management, Butterfly, Adjustment

Butterfly Network, Inc. (NYSE: BFLY) (Butterfly), a digital health company transforming care with handheld, whole-body ultrasound, today announced financial results for the quarter ended March 31, 2022, and provided a business update.

Key Points: 
  • Butterfly Network, Inc. (NYSE: BFLY) (Butterfly), a digital health company transforming care with handheld, whole-body ultrasound, today announced financial results for the quarter ended March 31, 2022, and provided a business update.
  • Butterfly Network received a $5 million grant from the Bill & Melinda Gates Foundation to improve maternal and fetal health in Sub-Saharan Africa with Butterfly iQ+.
  • Gross profit for the first quarter of 2022 was $8.3 million, compared to gross profit of $6.4 million in the first quarter of 2021.
  • A conference call to review the first quarter 2022 financial results and provide a business update is scheduled for May 5, 2022, at 8:30 am Eastern Time.

Petco and Butterfly Collaborate to Bring Cutting-Edge Ultrasound Technology to All Full-Service Veterinary Hospitals in Petco Pet Care Centers

Retrieved on: 
목요일, 5월 5, 2022
United Kingdom, PETS, Parent, Butterfly network, Forward-looking statement, Fowler & Wells Company, DVM, Nasdaq, Health, Wellness, New, Securities Exchange Act of 1934, NYSE, Securities Act of 1933, Partnership, Risk, Animal, Employee Retirement Income Security Act of 1974, Artificial intelligence, Mark (given name), Chief business development officer, Veterinarian, MBA, Solution, Goal, National Office of Animal Health, SAN, Medical imaging, Veterinary medicine, Butterfly

GUILFORD, Conn. and SAN DIEGO, May 5, 2022 /PRNewswire/ -- Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, and Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), a complete partner in pet health and wellness, today announced the parties have agreed to deploy Butterfly iQ+ Vet to Petco's growing network of nearly 200 full-service veterinary hospitals at Petco pet care centers.

Key Points: 
  • Butterfly Network is the first and only U.S. ultrasound imaging provider to collaborate with the health and wellness company for pets.
  • "As we continue bringing innovative technologies to the full-service veterinary hospitals in Petco pet care centers nationwide, we are thrilled to partner with Butterfly to increase pets' access to high-quality ultrasound imaging," said Petco's Chief Veterinarian, Dr. Whitney Miller , DVM, MBA, DACVPM.
  • "With the Butterfly iQ+ Vet, seeing is knowing," said Butterfly Network's Chief Strategy & Business Development Officer, Darius Shahida.
  • Our complete pet health and wellness ecosystem is accessible through our pet care centers and digitally at petco.com and on the Petco app .